(Q27466772)
Statements
667.14 dalton
1 reference
AC1N9ZJ9 (English)
19 October 2016
C₂₁H₃₁N₇O₁₄P₂
1 reference
AC1N9ZJ9 (English)
19 October 2016
C1C=CC(CN1C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C4N=CN=C5N)O)O)O)O)C(=O)N
1 reference
AC1N9ZJ9 (English)
19 October 2016
C1C=CC(CN1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4N=CN=C5N)O)O)O)O)C(=O)N
1 reference
AC1N9ZJ9 (English)
19 October 2016
Identifiers
1 reference
AC1N9ZJ9 (English)
19 October 2016
1 reference
AC1N9ZJ9 (English)
19 October 2016
1 reference
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-3,6-dihydro-2H-pyridin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methy (English)
19 October 2016
1 reference
AC1N9ZJ9 (English)
19 October 2016
1 reference
3GX9 (English)
19 October 2016
1 reference
3KRZ (English)
19 October 2016
1 reference
5IXS (English)
19 October 2016
1 reference
2OO5 (English)
19 October 2016
1 reference
2R14 (English)
19 October 2016